
Join to View Full Profile
The University of Texas MD Anderson Cancer Center1515 Holcombe BlvdHouston, TX 77030
Dr. Swaminathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University at BuffaloFellowship, Hematology and Medical Oncology, 2019 - 2022
- Carle Foundation HospitalResidency, Internal Medicine, 2014 - 2017
- OtherClass of 2012
Certifications & Licensure
- TX State Medical License 2017 - 2026
- NY State Medical License 2019 - 2022
- IL State Medical License 2014 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Clinicopathologic characteristics and outcomes of patients with clonal hematopoiesis who progress to myeloid neoplasms.Kelly S Chien, Julie S Braish, Ziyi Li, Sanam Loghavi, Alex Bataller
Leukemia. 2025-05-01 - 2 citationsClinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies.Jayastu Senapati, Sanam Loghavi, Jennifer Marvin-Peek, Guillermo Garcia-Manero, Tapan M Kadia
American Journal of Hematology. 2025-05-01 - 1 citationsReduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.Christophe Willekens, Alexandre Bazinet, Samy Chraibi, Alex Bataller, Justine Decroocq
Blood Cancer Journal. 2025-04-17
Authored Content
- The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II TrialOctober 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: